Filter
1

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: New Haven CT, Lake Success NY, The Bronx NY,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06545955

Phase3, Recruiting

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

for
Non-muscle-invasive Bladder Cancer
Location: Dallas TX, San Antonio TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT05825950

Recruiting

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

for
Locally Advanced Bladder Urothelial Carcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06764095

Recruiting

Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies

for
Prostate Cancer Stage I, Kidney Cancer Stage I,
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT03522155

Recruiting

Renal Retention in High Grade Upper Tract Urothelial Cancer

for
High Grade Urothelial Carcinoma, Bladder Cancer,
Location: Baltimore MD, Washington D.C. DC
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT05656235

Phase2, Recruiting

Interested in new bladder cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Halifax, Boston MA, The Bronx NY, New York NY,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase2, Recruiting

Telehealth Intervention for Ostomy Self-Management

for
Colorectal Cancer, Bladder Cancer
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06528990

Phase2, Recruiting

Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

for
Metastatic Bladder Urothelial Carcinoma,
Location: Chicago IL, Orland Park IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06630416

Phase2, Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Clasp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06778863

Phase1, Recruiting

Evaluation of the PhageTech Virus BioResistor

for
Bladder Cancer
Location: Santa Monica CA
Sponsor: PhageTech, Inc.

Sex: All

Age: 18+

Code: NCT04756284

Recruiting

Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade

for
Bladder Cancer
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 21+

Code: NCT02992990

Recruiting

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

for
Sarcoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06503146

Phase2, Recruiting

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

for
Advanced Bladder Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06434350

Phase1, Phase2, Recruiting

Evaluation for NCI Surgery Branch Clinical Research Protocols

for
Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT00001823

Recruiting

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

for
Non-muscle Invasive Bladder Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05126472

Phase1, Phase2, Recruiting

A Feasibility Randomized Trial Evaluating Early vs Late Stent Removal Following Radical Cystectomy and Ileal Conduit Formation for Bladder Cancer

for
Bladder Cancer Requiring Cystectomy, Ileal Conduit,
Location: London
Sponsor: Western University, Canada

Sex: All

Age: 18+

Code: NCT06595446

Recruiting

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

for
Urothelial Cancer, Cancer, Bladder Neoplasms,
Location: Burlington MA
Sponsor: Lahey Clinic

Sex: All

Age: 18+

Code: NCT00872495

Recruiting

Predicting BCG Response

for
Bladder Cancer
Location: Dallas TX, Los Angeles CA, San Francisco CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18 - 70+

Code: NCT04564781

Recruiting

Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC

for
Bladder Cancer
Location: Ottawa, Hamilton, London, Edmonton
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT04543110

Phase2, Recruiting

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

for
Urothelial Carcinoma Bladder, Bladder Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06586255

Phase1, Recruiting